Furthermore, we discovered that early-stage EGFR-mutant lung adenocarcinoma patients with high TLS expression demonstrated longer disease-free survival (DFS) compared to those with low TLS expression. The gene discussed is EGFR; the disease is lung adenocarcinoma.